Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > TD-4208 for Sale > 1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate buy - large image1
1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate buy - image1

1-(2-(3-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate

Unit Price: Get Latest Price
CAS No.:

864750-70-9

Content:

98%

Port:

上海

Packaging:

25KG/Drum

Sample Available:

Yes

Price valid (until):

2022-11-25

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,L/C
Average Lead Time:
14 days
Qualification:
Main Products:

9-bromophenanthrene,Fluorine-contained Benzoic acid series,sodium salty,Electronic Intermediates,Pharmaceutical Intermediates,Pheylurea

  • Product Description

  • Seller Information

  • Description


      Product Detail  


    Please enter the product introduction information...

    ItemsSpecifications
    AppearanceWhite or of- white powder or crystlline power,odorless
    SolubilityVery soluble in N,N-Dimethylformamide,Soluble in methanol,Sparingly soluble inglacial acetic acid, Very slightly soluble inchloroform, Practically insoluble in water.
    Melting Point152°C~156°C
    ECHEMI Editorial Reference
    Revefenacin is a novel biphenyl carbamate tertiary amine agent that belongs to the family of the long-acting muscarinic antagonists (LABA). The labile primary amide in the structure produces a "soft-drug" site that allows rapid systemic clearance and minimizing of the systemically mediated adverse reactions. The LABA group falls into a parent category known as long-acting inhaled bronchodilators and this type of agents are recommended as a maintenance therapy for chronic obstructive pulmonary disease (COPD). From the LABA group, revefenacin is the first once-daily nebulized LAMA treatment. It was developed by Theravance Biopharma and FDA approved on November 9, 2018.|Revefenacin is an Anticholinergic. The mechanism of action of revefenacin is as a Cholinergic Antagonist.|Revefenacin is a synthetic anticholinergic agent that is used as a once daily, nebulized inhalant for maintenance treatment of patients with chronic obstructive pulmonary disease. Revefenacin has not been implicated in causing liver enzyme elevations or clinically apparent acute liver injury.
    Revefenacin is a synthetic anticholinergic that is prescribed for the treatment of chronic obstructive pulmonary disease (COPD).

    Basic Info
    Product Name:

    TD-4208

    Other Name:

    TD-4208;Revefenacin / TD4208;GSK1160724;CPDD1221;Revefenacin:TD-4208:GSK-1160724;TD 4208;TD4208;1-(2-(4-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate;1-[2-[[4-[(4-carbamoylpiperidin-1-yl)methyl]benzoyl]-methylamino]ethyl]piperidin-4-yl] N-(2-phenylphenyl)carbamate

    CAS No.:

    864750-70-9

    Molecular Formula:

    C35H43N5O4

    InChIKeys:

    FYDWDCIFZSGNBU-UHFFFAOYSA-N

    Molecular Weight:

    597.75

    Exact Mass:

    597.75

    UNII:

    G2AE2VE07O

    Color/Form:

    White to off-white

    ATC Code:

    R - Respiratory system

    Characteristics
    PSA:

    108.21

    XLogP3:

    5.4851

    Density:

    1.26±0.1 g/cm3(Predicted)

    Melting Point:

    125 °C

    Boiling Point:

    777.5±60.0 °C(Predicted)

    Water Solubility:

    < 1 mg/ml

    PKA:

    13.34±0.70(Predicted)

    Critical Temperature & Pressure:

    Store at -20°C

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    9-bromophenanthrene,Fluorine-contained Benzoic acid series,sodium salty,Electronic Intermediates,Pharmaceutical Intermediates,Pheylurea

    Location:

    1513A, Shihong Building, Bixin Road, Longgang Dis, 518000, Shenzhen,Guang Dong Province, P. R. China.

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    14 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    51-100

    Year of Establishment:

    2015

    Speranza Chemical Co., Ltd. is a professional manufacturer of Fine Chemicals for more than 10years. Our Chemical factory locates in Handan Chemical Industry Zone, Hebei province with total invested of $12 million and area of 80,000 m².  
     
    We specialize in the development and manufacture of Pharmaceutical intermediates like Apixaban Intermediates and electronic chemicals like 9-bromophenanthrene(CAS No.573-17-1)(OLED intermediates ),  Organic Bromide like 1-bromo-4-chlorobenzene (CAS No.106-39-8),Iodide derivatives,Fluorine-contained Benzoic acid series,sodium salty for oil field and so on.
     


    Quality is our Culture and our Promise to our customers all over the world! From raw material purchasing to production progress, finish product testing and Packing, we insist to doing tracing and Quality control for each single step just to realize our promise and to be your trustworthy partner in China! Beyond competence products, we also do 7 X 24 hours After Sales Service!

     

    Speranza has set up long-term cooperation with many international companies as a trustworthy supplier.
     


    Speranza Chemical, Always getting better for our Customers and our Life!

    Email:sales08@speranzachem.com
    Tel:+86-755-21030354


  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.